For both DLBTau− and DLBTau+ patients, clusterin (CLU), a major genetic risk factor for late-onset Alzheimer’s disease (AD), also exhibited a higher expression (FDR-adjusted p-value < 0.05) and was the second most elevated protein in both subgroups [10]. Here, CLU is linked to Alzheimer disease.